Crowell & Moring’s Emerging Companies & Venture Capital team advised Marshall Wace, a global alternative asset manager, in its investment in Elektrofi’s Series B venture capital financing transaction. The deal, which closed on May 27, marks the latest in a growing number of successful venture investment representations on behalf of Marshall Wace. With this investment, Marshall Wace continues its healthcare crossover fund strategy, which has focused on innovative developers of new biotechnology, medical device applications, and more.
Elektrofi, a Boston-based biotechnology company focused on drug formulation and delivery innovations, is developing a formulation system to effectively process a wide range of therapeutic molecules. Its technology has the capacity to process large, increasingly complex, and delicate proteins—including monoclonal antibodies, bispecific, and fusion proteins that will enable researchers to discover and modify more advanced medicines.
The deal was led by Jon O’Connell with contributions from Justin Lurie and Justin Porter.
About Crowell & Moring LLP
Crowell & Moring LLP is an international law firm with offices in the United States, Europe, MENA, and Asia. Drawing on significant government, business, industry and legal experience, the firm helps clients capitalize on opportunities and provides creative solutions to complex litigation and arbitration, regulatory and policy, and corporate and transactional issues. The firm is consistently recognized for its commitment to pro bono service and its programs and initiatives to advance diversity, equity and inclusion.
